Amgen (AMGN) volatility August volatility at 47, October at 38
AMGN Hot Sheet
Overall Analyst Rating:NEUTRAL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: +9.5%
Amgen (Nasdaq: AMGN) : Amgen closed at $51.47. AMGN is scheduled to report Q2 EPS on July 27. AMGN's denosumab for treatment/prevention of postmenopausal osteoporosis and for bone loss in prostrate or breast cancer patients on hormone ablation therapy has a FDA action date of October 19. AMGN July option implied volatility is at 35, August is at 47, October is at 39; verses its six-month average of 42 according to Track Data. Paul Foster
You May Also Be Interested In
- Savient Pharma (SVNT) Moves Higher with Volatility; Bumps Up Against Key Resistance Point
- iShares MSCI EAFE Index Fund (EFA) Volatility Flat; Index Trends to Seven-Month Low
- Vodafone (VOD) Volatility Pops Early, Shares Inch Higher
Create E-mail Alert Related Categories
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
